Kuijper EJ - Search Results

1

Once versus thrice daily gentamicin in patients with serious infections.

Prins JM, Büller HR, Kuijper EJ, Tange RA, Speelman P. Prins JM, et al. Among authors: kuijper ej. Lancet. 1993 Feb 6;341(8841):335-9. doi: 10.1016/0140-6736(93)90137-6. Lancet. 1993. PMID: 8094114 Clinical Trial.

2

Easier monitoring of aminoglycoside therapy with once-daily dosing schedules.

Prins JM, Koopmans RP, Büller HR, Kuijper EJ, Speelman P. Prins JM, et al. Among authors: kuijper ej. Eur J Clin Microbiol Infect Dis. 1995 Jun;14(6):531-5. doi: 10.1007/BF02113434. Eur J Clin Microbiol Infect Dis. 1995. PMID: 7588829 Clinical Trial.

3

Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial.

Tange RA, Dreschler WA, Prins JM, Büller HR, Kuijper EJ, Speelman P. Tange RA, et al. Among authors: kuijper ej. Clin Otolaryngol Allied Sci. 1995 Apr;20(2):118-23. doi: 10.1111/j.1365-2273.1995.tb00026.x. Clin Otolaryngol Allied Sci. 1995. PMID: 7634515 Clinical Trial.

4

Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trial.

Prins JM, Büller HR, Kuijper EJ, Tange RA, Speelman P. Prins JM, et al. Among authors: kuijper ej. J Antimicrob Chemother. 1994 Apr;33(4):823-35. doi: 10.1093/jac/33.4.823. J Antimicrob Chemother. 1994. PMID: 8056701 Clinical Trial.

5

Mycobacterium xenopi in HIV-infected patients: an emerging pathogen.

Juffermans NP, Verbon A, Danner SA, Kuijper EJ, Speelman P. Juffermans NP, et al. Among authors: kuijper ej. AIDS. 1998 Sep 10;12(13):1661-6. doi: 10.1097/00002030-199813000-00014. AIDS. 1998. PMID: 9764786

6

Oral treatment of CAPD-peritonitis with ciprofloxacin.

Boeschoten EW, Kuijper EJ, Speelman P, Struijk DG, Krediet RT, Arisz L. Boeschoten EW, et al. Among authors: kuijper ej. Adv Perit Dial. 1990;6:126-9. Adv Perit Dial. 1990. PMID: 1982789 Clinical Trial.

7

Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime.

Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJ, Speelman P. Prins JM, et al. Among authors: kuijper ej. J Infect Dis. 1995 Sep;172(3):886-91. doi: 10.1093/infdis/172.3.886. J Infect Dis. 1995. PMID: 7658090 Clinical Trial.

8

Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum.

Prins JM, Kuijper EJ, Mevissen ML, Speelman P, van Deventer SJ. Prins JM, et al. Among authors: kuijper ej. Infect Immun. 1995 Jun;63(6):2236-42. doi: 10.1128/iai.63.6.2236-2242.1995. Infect Immun. 1995. PMID: 7768603 Free PMC article.

9

Clinical relevance of antibiotic-induced endotoxin release.

Prins JM, van Deventer SJ, Kuijper EJ, Speelman P. Prins JM, et al. Among authors: kuijper ej. Antimicrob Agents Chemother. 1994 Jun;38(6):1211-8. doi: 10.1128/AAC.38.6.1211. Antimicrob Agents Chemother. 1994. PMID: 8092816 Free PMC article. Review. No abstract available.

10

No increase in endotoxin release during antibiotic killing of meningococci.

Prins JM, Speelman P, Kuijper EJ, Dankert J, van Deventer SJ. Prins JM, et al. Among authors: kuijper ej. J Antimicrob Chemother. 1997 Jan;39(1):13-8. doi: 10.1093/jac/39.1.13. J Antimicrob Chemother. 1997. PMID: 9044022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

482 results

Search Page